Yi Su
Impact in
-
- Cancer-related molecular mechanisms research
-
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
Papers in
-
- Epigenetics and DNA Methylation 5
- Cancer-related gene regulation 3
- Histone Deacetylase Inhibitors Research 3
- RNA modifications and cancer 3
- Fibroblast Growth Factor Research 2
- Protein Degradation and Inhibitors 2
- RNA Research and Splicing 2
-
- Cancer-related molecular mechanisms research 2
- Co-authors
- Yanyan Shen (5 shared papers)Meiyu Geng (4 shared papers)Jian Ding (5 shared papers)Yi Chen (5 shared papers)Hong Yang (1 shared paper)Yafang Wang (1 shared paper)Min Huang (1 shared paper)Minjia Tan (1 shared paper)
- Journals
- Acta Pharmacologica Sinica (4 papers)Cell (1 paper)Frontiers in Oncology (1 paper)Nature Communications (1 paper)BioMed Research International (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Yi Su
19 papers receiving 555 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 85
- Molecular Biology 364
- Oncology 67
- Hematology 29
- Immunology 49
Countries citing papers authored by Yi Su
This map shows the geographic impact of Yi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Su more than expected).
Fields of papers citing papers by Yi Su
This network shows the impact of papers produced by Yi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Su. The network helps show where Yi Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 224 | |
| 2 | 2017 | 90 | |
| 3 | 2021 | 40 | |
| 4 | 2019 | 30 | |
| 5 | 2017 | 27 | |
| 6 | 2014 | 22 | |
| 7 | 2018 | 22 | |
| 8 | 2019 | 21 | |
| 9 | 2018 | 17 | |
| 10 | 2017 | 16 | |
| 11 | 2016 | 13 | |
| 12 | 2018 | 12 | |
| 13 | 2020 | 11 | |
| 14 | 2025 | 5 | |
| 15 | 2023 | 3 | |
| 16 | 2012 | 2 | |
| 17 | 2020 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2018 | 1 |
About Yi Su
Yi Su is a scholar working on Molecular Biology, Cancer Research, Immunology, Otorhinolaryngology and Endocrinology, having authored 19 papers that have together received 558 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (3 papers), Histone Deacetylase Inhibitors Research (3 papers), RNA modifications and cancer (3 papers), Fibroblast Growth Factor Research (2 papers), Cancer-related molecular mechanisms research (2 papers), Protein Degradation and Inhibitors (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (85 citations), Molecular Biology (364 citations), Oncology (67 citations), Hematology (29 citations) and Immunology (49 citations). Yi Su has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Yanyan Shen, Meiyu Geng, Jian Ding, Yi Chen, Hong Yang, Yafang Wang, Min Huang, Minjia Tan, Yi Chen and Rongrui Wei. Their work appears in journals such as Acta Pharmacologica Sinica, Cell, Frontiers in Oncology, Nature Communications and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.